Grant opportunity · RFA-DA-26-034
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Who can apply (as listed)
- State governments
- Native American tribal organizations (other than federally recognized governments)
- Private institutions of higher education
- For-profit organizations (other than small businesses)
- Native American tribal governments (federally recognized)
- Special district governments
- Public and state-controlled institutions of higher education
- Independent school districts
- Public housing authorities / Indian housing authorities
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- County governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Others (see the opportunity text)
- City or township governments
- Small businesses
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.